Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-038093)

Filing Details

Accession Number:: 0001209191-19-038093
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-06-19 17:48:33
Reporting Period:: 2017-11-22

Accepted Time:: 2019-06-19 17:48:33
Original Submission Date:: 2019-06-19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299430	D Christopher Alafi	C/O Alafi Capital Company, Llc 8 Admiral Drive, Suite 324 Emeryville CA 94608		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-22	10,000	$15.55	3,963,270	No	4	P	Indirect	Held by Alafi Capital Company, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Alafi Capital Company, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	734,466	Direct

Footnotes

Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.